BEZIN, Julien; MOORE, Nicholas

doi:10.1016/j.therap.2019.01.004

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

BEZIN, Julien

Bordeaux population health [BPH]

MOORE, Nicholas

Bordeaux population health [BPH]

Langue

Article de revue

Ce document a été publié dans

Thérapie. 2019, vol. 74, n° 2, p. 261-269

Résumé en anglais

The evaluation of the real-life benefits and risks of statins in population is a major pharmacoepidemiological issue, given their widespread use for cardiovascular prevention. The purpose of this review was not to be exhaustive but to show the contributions of pharmacoepidemiology for various aspects of the evaluation of statins such as real-life drug use, effectiveness and risk. Statins are among the most used drugs in the world, but recent data show a slight decrease in use. Actual statin users are older, and have more comorbidities than those studied in clinical trials, but this does not seem to compromise their effectiveness, unlike the compliance issues that are common with these drugs. Beyond the known adverse reactions of statins from the clinical trials, risks of statins can be varied and sometimes difficult to evaluate, considering the ubiquity of cholesterol throughout the body, from drug or endogenous molecule metabolism to the construction of cell membranes or cell activities.< Réduire

Mots clés en anglais

PharmacoEpi-Drugs

CIC1401

Métadonnées

Partager cette publication !

Licence d’utilisation du document

Pharmacoepidemiology of statins

Langue

Ce document a été publié dans

Résumé en anglais

Mots clés en anglais

URI

DOI

Unités de recherche